| 1 |
32783069 | Interleukin-17A up-regulates thymic stromal lymphopoietin production by nasal fibroblasts from patients with allergic rhinitis. | 2021 Jan |
1 |
| 2 |
33119735 | Psoriasis-like skin disorder in transgenic mice expressing a RIG-I Singleton-Merten syndrome variant. | 2021 Mar 31 |
1 |
| 3 |
33899926 | Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis. | 2021 Aug |
2 |
| 4 |
32808031 | The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation. | 2020 Aug 18 |
1 |
| 5 |
31780862 | Changes in Serum Cytokines May Predict Therapeutic Efficacy of Tofacitinib in Rheumatoid Arthritis. | 2019 |
1 |
| 6 |
29748971 | Association between serum interleukin-17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis. | 2018 Oct |
2 |
| 7 |
28994166 | Newer treatments of psoriasis regarding IL-23 inhibitors, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors. | 2017 Nov |
1 |
| 8 |
24342887 | Effects of topical Janus kinase inhibition on ocular surface inflammation and immunity. | 2014 Feb |
1 |
| 9 |
22147632 | The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells. | 2012 Jun |
4 |
| 10 |
22460142 | In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis. | 2012 Apr |
2 |
| 11 |
22607938 | Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease. | 2012 Jul |
1 |
| 12 |
20965150 | Therapeutic effect of IL-12/23 and their signaling pathway blockade on brain ischemia model. | 2010 Nov 19 |
1 |